Muhammad Wasif Saif (M Wasif Saif)

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 6

Top Topics

Metastatic Colorectal Cancer

Top Venues

OncoTargets and therapy

JCO oncology practice

British journal of clinical pharmacology

Case reports in oncological medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel A King, Robert B Diasio, Muhammad Wasif Saif
Association of Pharmacogenetics With Adverse Events of Fluorouracil/Capecitabine in Patients With Cancer. JCO oncology practice 17 (7) (2021)
Muhammad Wasif Saif, Carlos R Becerra, Marwan G Fakih, Weijing Sun, Lazar Popovic, Smitha Krishnamurthi, Thomas J George, Michelle A Rudek, Dale R Shepard, Jiri Skopek, Vladimir Sramek, Bojan Zaric, Ikuo Yamamiya, Karim A Benhadji, Kensuke Hamada, Yaohua He, Lee Rosen
A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment. Cancer chemotherapy and pharmacology 88 (3) (2021)
Muhammad Wasif Saif
Alternative Treatment Options in Patients with Colorectal Cancer Who Encounter Fluoropyrimidine-Induced Cardiotoxicity. OncoTargets and therapy 13 (2020)
Jeffrey Chi, Jennifer Park, Muhammad Wasif Saif
Ibrutinib-Induced Vasculitis in a Patient with Metastatic Colon Cancer Treated in Combination with Cetuximab. Case reports in oncological medicine 2020 (2020)
Manish M Karamchandani, Tej Ganti, Sunny Jaiswal, Julian K Wu, Muhammad Wasif Saif
A Rare Occurrence of Isolated Brain Metastases from Gastric Cancer. Case reports in medicine 2019 (2019)
Muhammad Wasif Saif, Lee Rosen, Michelle A Rudek, Weijing Sun, Dale R Shepard, Carlos Becerra, Fumiaki Yamashita, Paul Bebeau, Robert Winkler
Open-label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment. British journal of clinical pharmacology 85 (6) (2019)